We aim to create a space in which students can learn about the overall picture of each academic field and the organic connections between them.
Features of Global Focus on Knowledge
Global Focus on Knowledge aims to enable undergraduate students in their first and second years—students who are standing at the doorway to academia—to see great knowledge systems and their structures from a wider perspective, and in so doing create a space where students learn about the overall picture of each academic field and the organic connections between them.
In the present day, when our knowledge is expanding and is intertwined in complex ways, you may find that the academic field you are trying to study unexpectedly intersects other areas.
Venture into a variety of fields, regardless of whether they are classed as arts or sciences.
- Regular courses (arts/sciences) for the Junior Division (Years 1&2) in the College of Arts and Science, the University of Tokyo
- Thematic Courses > Academic Frontier Lecture Series > Global Focus on Knowledge (two credits)
- Past lectures available on UTokyo OCW
- Students of the arts can take science lectures and science students can take arts lectures.
- Numerous interdisciplinary lectures featuring topics such as collaboration between medicine and engineering and fusions of humanities and sciences
Examples of Global Focus on Knowledge programs (FY2019)
The following lectures were held in FY2019, based on the theme of “Delivering New Medical Treatments and Products to Our Society – A Healthy Society Created by Data Science”:
- “Data Science in Healthcare” by Yutaka Matsuyama (Faculty of Medicine)
- “Cancer Treatment in the New Era Using Genome Information and Artificial Intelligence” by Seiya Imoto (The Institute of Medical Science)
- “What does it Mean for the Government to ‘Approve’ the ‘Effectiveness of a Drug’?” by Shunsuke Ono (Faculty of Pharmaceutical Sciences)
- “Development of Treatments in Regenerative Medicine” by Masayo Takahashi (RIKEN)
- “How to Conduct a Clinical Trial and to Interpret its Results” by Yasuo Ohashi (Chuo University)
- “Significance of Clinical Research Conducted by Academia” by Yasuhiro Fujiwara (National Cancer Center Japan)
- “Safety Evaluation of Drugs (Pharmacoepidemiology) Using Healthcare Big Data” by Daisuke Koide (The University of Tokyo Hospital)
- “Developing a Cancer Diagnosis-Assistant Machine Based on Mass Spectrometry and Artificial Intelligence: Interdisciplinary Research Jumping into Industry-Academia Collaboration” by Sen Takeda (University of Yamanashi) and Kunio Tanabe (Waseda University)
- “Clinical Epidemiology: Science Addressing the Uncertainty in Healthcare” by Hideo Yasunaga (Faculty of Medicine)
- “Lives and Money, Drugs and Money… What is the Cost-Effectiveness of Drugs?” by Ataru Igarashi (Faculty of Pharmaceutical Sciences)
- “How New Medical Treatments and Information Should Be Delivered to Patients and Citizens?” by Tomoko Takayama (National Cancer Center Japan)
The following course was held in FY2020:”Thinking about Infectious Diseases”
Coordinator: Kei Sato (The Institute of Medical Science)